ACRO Biomedical, a pioneer in the field of regenerative medicine, is committed to the research, development and production of biomedical materials for human tissue and organ regeneration. Following ABCcolla^® Bone Graft and ABCcolla^® Dental Bone Graft, ABCcolla^® Bone Matrix has been certified by the Ministry of Health and Welfare and the US FDA 510 (k) K212156, and awarded Symbol of National Quality, which proves that the company's regenerative medicine technology has its own uniqueness and has the ability to transform technology into products for patients benefits.

ABCcolla^® Bone Matrix is a decellularized native porcine bone graft material prepared by supercritical CO₂ extraction technology, which is composed of native porcine collagen and bone matrix that are comparable to the human bone matrix. During the healing process, ABCcolla^® Bone Matrix gradually resorbs and is replenished by new bone.